Aduro Biotech
ADRO
#8312
Rank
โ‚น21.34 B
Marketcap
โ‚น1,317
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): โ‚น2.07 Billion

According to Aduro Biotech's latest financial reports the company's current revenue is โ‚น2.52 Billion. In 2019 the company made a revenue of โ‚น1.55 Billion an increase over the revenue in the year 2018 that were of โ‚น1.36 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚น2.07 B33.09%
2019โ‚น1.55 B14.39%
2018โ‚น1.36 B-12.48%
2017โ‚น1.55 B-65.99%
2016โ‚น4.57 B-30.55%
2015โ‚น6.58 B445.07%
2014โ‚น1.20 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น217.77 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น63.87 B 2,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น7.54 B 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น86.77 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany